Knock-out-Zertifikate finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
78 Ergebnisse
| JZ51D6 | Alnylam Pharmaceuticals Inc./KO/Put [endlos]/JPMD | - | - | put | Alnylam Pharmaceuticals Inc. | 430,274 | 387,200 | 1,688 | 42,683 % | - | JP Morgan | ||
| JZ60XT | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/JPMD | - | - | call | Alnylam Pharmaceuticals Inc. | 176,990 | 176,990 | 2,730 | 34,779 % | - | JP Morgan | ||
| JZ6NVT | Alnylam Pharmaceuticals Inc./KO/Put [endlos]/JPMD | - | - | put | Alnylam Pharmaceuticals Inc. | 387,436 | 387,436 | 2,158 | 42,770 % | - | JP Morgan | ||
| JZ6PTL | Alnylam Pharmaceuticals Inc./KO/Put [endlos]/JPMD | - | - | put | Alnylam Pharmaceuticals Inc. | 407,105 | 407,105 | 1,933 | 50,018 % | - | JP Morgan | ||
| JZ7K5A | Alnylam Pharmaceuticals Inc./KO/Put [endlos]/JPMD | - | - | put | Alnylam Pharmaceuticals Inc. | 417,035 | 417,035 | 1,859 | 53,678 % | - | JP Morgan | ||
| JZ7P51 | Alnylam Pharmaceuticals Inc./KO/Put [endlos]/JPMD | - | - | put | Alnylam Pharmaceuticals Inc. | 397,236 | 397,236 | 2,179 | 46,382 % | - | JP Morgan | ||
| MG06K7 |  | Alnylam Pharmaceuticals Inc./Faktor/Long [5]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 218,185 | 218,185 | 4,747 | 19,599 % | - | Morgan Stanley | |
| MG2XFZ | | Alnylam Pharmaceuticals Inc./Faktor/Long [6]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 227,276 | 227,276 | 5,835 | 16,249 % | - | Morgan Stanley | |
| MG6A5H | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 142,863 | 168,580 | 2,005 | 37,878 % | - | Morgan Stanley | |
| MG6WDN | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 162,649 | 191,930 | 2,534 | 29,274 % | - | Morgan Stanley | |
| MG6X19 | | Alnylam Pharmaceuticals Inc./Faktor/Long [4]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 204,549 | 204,549 | 3,775 | 24,624 % | - | Morgan Stanley | |
| MG6X1A | | Alnylam Pharmaceuticals Inc./Faktor/Long [5]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 218,185 | 218,185 | 4,900 | 19,599 % | - | Morgan Stanley | |
| MG6X76 | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 179,931 | 179,931 | 2,868 | 33,695 % | - | Morgan Stanley | |
| MG6X78 | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 203,922 | 203,922 | 3,819 | 24,855 % | - | Morgan Stanley | |
| MG783L | | Alnylam Pharmaceuticals Inc./Faktor/Long [3]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 181,821 | 181,821 | 2,876 | 32,999 % | - | Morgan Stanley | |
| MJ6XU3 | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 194,477 | 229,490 | 3,471 | 15,433 % | - | Morgan Stanley | |
| MK17QY | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 152,928 | 180,460 | 2,271 | 33,500 % | - | Morgan Stanley | |
| MK5DGN | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 244,737 | 244,737 | - | 9,814 % | - | Morgan Stanley | |
| MK6NK1 | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 232,470 | 232,470 | 6,360 | 14,335 % | - | Morgan Stanley | |
| MK95AW | | Alnylam Pharmaceuticals Inc./Faktor/Short [2]/MS | - | - | put | Alnylam Pharmaceuticals Inc. | 408,995 | 408,995 | 2,104 | 50,715 % | - | Morgan Stanley | |
| MK95AX | | Alnylam Pharmaceuticals Inc./Faktor/Short [4]/MS | - | - | put | Alnylam Pharmaceuticals Inc. | 340,829 | 340,829 | 4,326 | 25,596 % | - | Morgan Stanley | |
| MM1MQQ | | Alnylam Pharmaceuticals Inc./Faktor/Short [5]/MS | - | - | put | Alnylam Pharmaceuticals Inc. | 327,196 | 327,196 | 5,503 | 20,572 % | - | Morgan Stanley | |
| MM1MV5 | | Alnylam Pharmaceuticals Inc./Faktor/Long [2]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 136,366 | 136,366 | 1,955 | 49,749 % | - | Morgan Stanley | |
| MM20JL | | Alnylam Pharmaceuticals Inc./Faktor/Short [3]/MS | - | - | put | Alnylam Pharmaceuticals Inc. | 363,551 | 363,551 | 3,197 | 33,969 % | - | Morgan Stanley | |
| MN11W8 | | Alnylam Pharmaceuticals Inc./KO/Put [endlos]/MS | - | - | put | Alnylam Pharmaceuticals Inc. | 398,191 | 398,191 | 2,149 | 46,733 % | - | Morgan Stanley | |
| MN9KUT | | Alnylam Pharmaceuticals Inc./KO/Call [endlos]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 215,180 | 253,920 | 4,662 | 6,430 % | - | Morgan Stanley | |
| MR1XNL | | Alnylam Pharmaceuticals Inc./Faktor/Long [4]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 204,549 | 204,549 | - | 24,624 % | - | Morgan Stanley | |
| MR426K | | Alnylam Pharmaceuticals Inc./Faktor/Long [5]/MS | - | - | call | Alnylam Pharmaceuticals Inc. | 218,185 | 218,185 | - | 19,599 % | - | Morgan Stanley |